1 Department of Pediatrics, Amager and Hvidovre Hospital, The Capital Region of Denmark2 Paediatrics, Herlev and Gentofte Hospital, The Capital Region of Denmark
Children chronically infected with hepatitis B virus (HBV) are at high risk of progressive liver disease. However, no treatment is available that is consistently effective in curing chronic hepatitis B (CHB) in children. Improved understanding of the natural course of disease is warranted. Identification of specific microRNA (miRNA) profiles in children chronically infected with HBV may provide insight into the pathogenesis of CHB and lead to advances in the management of children with CHB.